Porter , C. “Tyrosine Kinase Inhibitors in Hematologic Malignancy: Should We Be Concerned?”. OncoReview, Vol. 6, no. 1(21), Feb. 2016, pp. 11-13, doi:10.5604/20828691.1198514.